Cargando…

Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome

Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Martinez, Espiridión, Vega-Sánchez, Angel E., Pérez-Rubio, Gloria, Mejia, Mayra, Buendía-Roldán, Ivette, González-Pérez, Montserrat I., Mateos-Toledo, Heidegger N., Andrade, Warrison A., Falfán-Valencia, Ramcés, Rojas-Serrano, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818379/
https://www.ncbi.nlm.nih.gov/pubmed/36611853
http://dx.doi.org/10.3390/cells12010060
_version_ 1784864971336712192
author Ramos-Martinez, Espiridión
Vega-Sánchez, Angel E.
Pérez-Rubio, Gloria
Mejia, Mayra
Buendía-Roldán, Ivette
González-Pérez, Montserrat I.
Mateos-Toledo, Heidegger N.
Andrade, Warrison A.
Falfán-Valencia, Ramcés
Rojas-Serrano, Jorge
author_facet Ramos-Martinez, Espiridión
Vega-Sánchez, Angel E.
Pérez-Rubio, Gloria
Mejia, Mayra
Buendía-Roldán, Ivette
González-Pérez, Montserrat I.
Mateos-Toledo, Heidegger N.
Andrade, Warrison A.
Falfán-Valencia, Ramcés
Rojas-Serrano, Jorge
author_sort Ramos-Martinez, Espiridión
collection PubMed
description Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients with ASSD and a comparison group of systemic sclerosis (SSc) patients. Cytokines and lactate dehydrogenase (LDH) were determined using the concentrated BAL protein. The activity of caspase-1 and concentration of NLRP3 with the protein purified from the cell pellet in each group of patients. We found higher caspase-1 levels in ASSD vs. SSc, 1.25 RFU vs. 0.75 RFU p = 0.003, and LDH levels at 0.15 OD vs. 0.09 OD p < 0.001. A significant difference was observed in molecules associated with inflammasome activation, IL-18: 1.42 pg/mL vs. 0.87 pg/mL p = 0.02 and IFN-γ: 0.9 pg/mL vs. 0.86 pg/mL, p = 0.01. A positive correlation was found between caspase-1 and LDH in the patients with ASSD Rho 0.58 (p = 0.008) but not in the SSc group. In patients with ASSD, greater caspase-1 and higher LDH activity were observed in BAL, suggesting cell death due to pyroptosis and activation of the inflammasome pathway.
format Online
Article
Text
id pubmed-9818379
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98183792023-01-07 Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome Ramos-Martinez, Espiridión Vega-Sánchez, Angel E. Pérez-Rubio, Gloria Mejia, Mayra Buendía-Roldán, Ivette González-Pérez, Montserrat I. Mateos-Toledo, Heidegger N. Andrade, Warrison A. Falfán-Valencia, Ramcés Rojas-Serrano, Jorge Cells Article Anti-synthetase syndrome (ASSD) is an autoimmune disorder characterized by inflammatory interstitial lung disease (ILD). The main objective of this work was to quantify the concentrations of cytokines and molecules associated with inflammasome activation in bronchoalveolar lavage (BAL) of patients with ASSD and a comparison group of systemic sclerosis (SSc) patients. Cytokines and lactate dehydrogenase (LDH) were determined using the concentrated BAL protein. The activity of caspase-1 and concentration of NLRP3 with the protein purified from the cell pellet in each group of patients. We found higher caspase-1 levels in ASSD vs. SSc, 1.25 RFU vs. 0.75 RFU p = 0.003, and LDH levels at 0.15 OD vs. 0.09 OD p < 0.001. A significant difference was observed in molecules associated with inflammasome activation, IL-18: 1.42 pg/mL vs. 0.87 pg/mL p = 0.02 and IFN-γ: 0.9 pg/mL vs. 0.86 pg/mL, p = 0.01. A positive correlation was found between caspase-1 and LDH in the patients with ASSD Rho 0.58 (p = 0.008) but not in the SSc group. In patients with ASSD, greater caspase-1 and higher LDH activity were observed in BAL, suggesting cell death due to pyroptosis and activation of the inflammasome pathway. MDPI 2022-12-23 /pmc/articles/PMC9818379/ /pubmed/36611853 http://dx.doi.org/10.3390/cells12010060 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ramos-Martinez, Espiridión
Vega-Sánchez, Angel E.
Pérez-Rubio, Gloria
Mejia, Mayra
Buendía-Roldán, Ivette
González-Pérez, Montserrat I.
Mateos-Toledo, Heidegger N.
Andrade, Warrison A.
Falfán-Valencia, Ramcés
Rojas-Serrano, Jorge
Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title_full Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title_fullStr Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title_full_unstemmed Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title_short Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
title_sort enhanced activity of nlrp3 inflammasome in the lung of patients with anti-synthetase syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818379/
https://www.ncbi.nlm.nih.gov/pubmed/36611853
http://dx.doi.org/10.3390/cells12010060
work_keys_str_mv AT ramosmartinezespiridion enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT vegasanchezangele enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT perezrubiogloria enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT mejiamayra enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT buendiaroldanivette enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT gonzalezperezmontserrati enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT mateostoledoheideggern enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT andradewarrisona enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT falfanvalenciaramces enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome
AT rojasserranojorge enhancedactivityofnlrp3inflammasomeinthelungofpatientswithantisynthetasesyndrome